A Prospective, Single-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection as Compared to the Saline Placebo Injection in the Treatment of Plantar Fasciitis

Trial Profile

A Prospective, Single-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection as Compared to the Saline Placebo Injection in the Treatment of Plantar Fasciitis

Recruiting
Phase of Trial: Phase II/III

Latest Information Update: 31 Oct 2017

At a glance

  • Drugs DHACM (Primary)
  • Indications Plantar fasciitis
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors MiMedx
  • Most Recent Events

    • 24 Oct 2017 Planned End Date changed from 1 Jul 2017 to 1 Dec 2018.
    • 24 Oct 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Oct 2018.
    • 07 Aug 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top